Package Quantity: 50/Pkg Active Ingredient: verdinexor Presentation: Tablet
Choose a comparable product or call 1-800-225-7911 for assistance

Laverdia™-CA1 is the first oral tablet FDA conditionally approved to treat lymphoma in dogs.

  • Verdinexor is a selective inhibitor of nuclear export CRM1/XPO1 protein
  • The active ingredient in Laverdia-CA1 is verdinexor, a substance that works by preventing tumor suppressing proteins from leaving the nucleus of cells, resulting in disruption of cancer cell survival and eventual cancer cell death

NDC Number: 86121-0003-01 Active Ingredient: verdinexor Package Quantity: 50/Pkg Strength: 50 mg Presentation: Tablet Pill Count: 50/Pkg Container Type: Bottle For Animal Type: Dog

02/01/2023 - 03/31/2023
Valid from February 1, 2023 - March 31, 2023. *Vets* Buy any 2 bottles of Laverdia-CA1, Get 1 bottle FREE! *Mix and match *Free goods will be lowest price product purchased *Must have valid VCPR *Promotions will not be honored on back orders or out of stock items

Promotions Expiration: 03/31/2023